Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias R Bauer

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Structure (London, England : 1993)|December 5, 2015
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53Andreas C Joerger, Matthias R Bauer, Rainer Wilcken, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2Simon M Vogel, Matthias R Bauer, Andreas C Joerger, et al.
Journal of Medicinal Chemistry|December 30, 2010
Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer propertiesHeba A Mohamed, Nancy M R Girgis, Rainer Wilcken, et al.
Future Medicinal Chemistry|October 22, 2019
A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220CMatthias R Bauer, Rhiannon N Jones, Raysa K Tareque, et al.
Cancer Letters|October 26, 2017
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007Naoise C Synnott, Matthias R Bauer, Stephen Madden, et al.
Chemmedchem|May 20, 2026
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group IdentificationSophie Racine, Odile Decoret, Marco Palmieri, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
Cancers|August 14, 2019
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular CarcinomaSara Gomes, Bartolomeo Bosco, Joana B Loureiro, et al.
Chemmedchem|December 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold MorphingJuraj Velcicky, Estelle Ngo, Matthias R Bauer, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2018
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathwayChristopher C T Sng, Sorcha O'Byrne, Daniil M Prigozhin, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Structure (London, England : 1993)|December 5, 2015
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53Andreas C Joerger, Matthias R Bauer, Rainer Wilcken, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2Simon M Vogel, Matthias R Bauer, Andreas C Joerger, et al.
Journal of Medicinal Chemistry|December 30, 2010
Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer propertiesHeba A Mohamed, Nancy M R Girgis, Rainer Wilcken, et al.
Future Medicinal Chemistry|October 22, 2019
A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220CMatthias R Bauer, Rhiannon N Jones, Raysa K Tareque, et al.
Cancer Letters|October 26, 2017
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007Naoise C Synnott, Matthias R Bauer, Stephen Madden, et al.
Chemmedchem|May 20, 2026
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group IdentificationSophie Racine, Odile Decoret, Marco Palmieri, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
Cancers|August 14, 2019
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular CarcinomaSara Gomes, Bartolomeo Bosco, Joana B Loureiro, et al.
Chemmedchem|December 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold MorphingJuraj Velcicky, Estelle Ngo, Matthias R Bauer, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2018
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathwayChristopher C T Sng, Sorcha O'Byrne, Daniil M Prigozhin, et al.
Pageof 4